Artificial Intelligence Predicts Next Session’s Price Change For Cigna, Eli Lilly And Company, Pfizer

(VIANEWS) – Today, the AICapitalize artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Cigna CI, Eli Lilly and Company LLY and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

AICapitalize provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

AICapitalize officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

1. Cigna (CI)

Shares of Cigna rose by a staggering 11.98% in from $305.22 to $341.79 at 18:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Volatility

Cigna’s last week, last month’s, and last quarter’s current intraday variation average was 0.36%, 0.59%, and 1.28%.

Cigna’s highest amplitude of average volatility was 0.36% (last week), 0.91% (last month), and 1.28% (last quarter).

Moving Average

Cigna’s worth is way above its 50-day moving average of $306.44 and way above its 200-day moving average of $287.49.

Yearly Top and Bottom Value

Cigna’s stock is valued at $341.79 at 18:21 EST, below its 52-week high of $342.74 and way above its 52-week low of $240.50.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 14.4% and 13.1%, respectively.

More news about Cigna.

2. Eli Lilly and Company (LLY)

Shares of Eli Lilly and Company rose by a staggering 19.95% in from $630.8 to $756.65 at 18:21 EST on Tuesday, after four sequential sessions in a row of gains. NYSE is falling 0.4% to $17,340.17, following the last session’s downward trend.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Sales Growth

Eli Lilly and Company’s sales growth is 29.7% for the present quarter and 19% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 34.12B for the twelve trailing months.

More news about Eli Lilly and Company.

3. Pfizer (PFE)

Shares of Pfizer fell 2.72% in from $28.35 to $27.58 at 18:21 EST on Tuesday, after three sequential sessions in a row of gains. NYSE is dropping 0.4% to $17,340.17, following the last session’s downward trend.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; Abrocitinib, under CIBINQO; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Sales Growth

Pfizer’s sales growth is negative 41.2% for the present quarter and negative 10.3% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 119.3% and a negative 50.4%, respectively.

More news about Pfizer.

4. Vulcan Materials Company (VMC)

Shares of Vulcan Materials Company jumped by a staggering 10.95% in from $227.1 to $251.97 at 18:21 EST on Tuesday, after five successive sessions in a row of gains. NYSE is dropping 0.4% to $17,340.17, following the last session’s downward trend.

Vulcan Materials Company, together with its subsidiaries, produces and supplies construction aggregates primarily in the United States. It operates through four segments: Aggregates, Asphalt, Concrete, and Calcium. The Aggregates segment provides crushed stones, sand and gravel, sand, and other aggregates; and related products and services that are applied in construction and maintenance of highways, streets, and other public works, as well as in the construction of housing and commercial, industrial, and other nonresidential facilities. The Asphalt Mix segment offers asphalt mix in Alabama, Arizona, California, New Mexico, Tennessee, and Texas, as well as engages in the asphalt construction paving activity in Alabama, Tennessee, and Texas. The Concrete segment provides ready-mixed concrete in California, Maryland, New Jersey, New York, Oklahoma, Pennsylvania, Texas and Virginia, and Washington D.C. The Calcium segment mines, produces, and sells calcium products for the animal feed, plastics, and water treatment industries. The company was formerly known as Virginia Holdco, Inc. and changed its name to Vulcan Materials Company. Vulcan Materials Company was founded in 1909 and is headquartered in Birmingham, Alabama.

Volatility

Vulcan Materials Company’s last week, last month’s, and last quarter’s current intraday variation average was 2.49%, 0.61%, and 1.02%.

Vulcan Materials Company’s highest amplitude of average volatility was 2.49% (last week), 1.56% (last month), and 1.02% (last quarter).

More news about Vulcan Materials Company.

5. American Electric Power Company (AEP)

Shares of American Electric Power Company rose 4.85% in from $77.08 to $80.82 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

American Electric Power Company, Inc., an electric public utility holding company, engages in the generation, transmission, and distribution of electricity for sale to retail and wholesale customers in the United States. It operates through Vertically Integrated Utilities, Transmission and Distribution Utilities, AEP Transmission Holdco, and Generation & Marketing segments. The company generates electricity using coal and lignite, natural gas, renewable, nuclear, hydro, solar, wind, and other energy sources. It also supplies and markets electric power at wholesale to other electric utility companies, rural electric cooperatives, municipalities, and other market participants. The company was incorporated in 1906 and is headquartered in Columbus, Ohio.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, American Electric Power Company’s stock is considered to be oversold (<=20).

Moving Average

American Electric Power Company’s worth is higher than its 50-day moving average of $80.11 and above its 200-day moving average of $80.81.

More news about American Electric Power Company.

6. Pembina Pipeline (PBA)

Shares of Pembina Pipeline fell 0.39% in from $33.76 to $33.63 at 18:21 EST on Tuesday, after three consecutive sessions in a row of gains. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

Pembina Pipeline Corporation provides energy transportation and midstream services. It operates through three segments: Pipelines, Facilities, and Marketing & New Ventures. The Pipelines segment operates conventional, oil sands and heavy oil, and transmission assets with a transportation capacity of 2.8 millions of barrels of oil equivalent per day, the ground storage capacity of 11 millions of barrels, and rail terminalling capacity of approximately 105 thousands of barrels of oil equivalent per day serving markets and basins across North America. The Facilities segment offers infrastructure that provides customers with natural gas, condensate, and natural gas liquids (NGLs), including ethane, propane, butane, and condensate; and includes 354 thousands of barrels per day of NGL fractionation capacity, 21 millions of barrels of cavern storage capacity, and associated pipeline and rail terminalling facilities. The Marketing & New Ventures segment buys and sells hydrocarbon liquids and natural gas originating in the Western Canadian sedimentary basin and other basins. Pembina Pipeline Corporation was founded in 1954 and is headquartered in Calgary, Canada.

Volatility

Pembina Pipeline’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.82%, a negative 0.01%, and a positive 0.72%.

Pembina Pipeline’s highest amplitude of average volatility was 0.82% (last week), 0.73% (last month), and 0.72% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Pembina Pipeline’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

Pembina Pipeline’s stock is valued at $33.63 at 18:21 EST, under its 52-week high of $36.29 and way above its 52-week low of $28.15.

More news about Pembina Pipeline.

7. Orix Corp (IX)

Shares of Orix Corp rose 5.83% in from $96.73 to $102.37 at 18:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is falling 0.4% to $17,340.17, following the last session’s downward trend.

ORIX Corporation provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East. The company's Corporate Financial Services and Maintenance Leasing segment is involved in the finance and fee; leasing and rental of automobiles, electronic measuring instruments, and ICT-related equipment businesses; and provision of life insurance and environment and energy-related products and services. Its Real Estate segment develops, rents, and manages real estate properties; operates facilities; real estate asset management; manages residential condominiums and office building; and provides construction contracting, real estate brokerage, and real estate investment advisory services, as well as operates hotels and Japanese inns. The company's PE Investment and Concession segment engages in the private equity (PE) investment and concession businesses. Its Environment and Energy segment provides renewable energy; ESCO; retails electric power; sells solar panels and battery electricity storage systems; and recycling and waste management services, as well as generates solar power. The company's Insurance segment sells life insurance products through agents, banks, and other financial institutions, as well as face-to-face and online. Its Banking and Credit segment provides banking and consumer finance services. The company's Aircraft and Ships segment engages in the aircraft leasing and management, and ship-related finance and investment businesses. Its ORIX USA segment offers finance, investment, and asset management services. The company's ORIX Europe segment provides equity and fixed income asset management services. Its Asia and Australia segment offers finance and investment businesses. The company was formerly known as Orient Leasing Co., Ltd. and changed its name to ORIX Corporation in 1989. ORIX Corporation was incorporated in 1950 and is headquartered in Tokyo, Japan.

Moving Average

Orix Corp’s value is above its 50-day moving average of $95.35 and way higher than its 200-day moving average of $92.02.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 2.71T for the twelve trailing months.

Yearly Top and Bottom Value

Orix Corp’s stock is valued at $102.37 at 18:21 EST, higher than its 52-week high of $102.15.

More news about Orix Corp.

8. LyondellBasell (LYB)

Shares of LyondellBasell rose 2.57% in from $93.9 to $96.31 at 18:21 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is falling 0.4% to $17,340.17, following the last session’s downward trend.

LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and Polyolefins—Americas; Olefins and Polyolefins—Europe, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. It produces and markets olefins and co-products, polyethylene, and polypropylene; and propylene oxide and derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomer, acetyls, ethylene oxide, and ethylene glycol. In addition, the company produce and markets compounding and solutions including polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors and powders, and advanced polymers including catalloy and polybutene-1; and refines heavy, high-sulfur crude oil and other crude oils, as well as refined products, including gasoline and distillates. Further, it develops and licenses chemical and polyolefin process technologies; manufactures and sells polyolefin catalysts; and serves food packaging, home furnishings, automotive components, and paints and coatings applications. The company was incorporated in 2009 and is headquartered in Houston, Texas.

More news about LyondellBasell.

9. PT Telekomunikasi (TLK)

Shares of PT Telekomunikasi jumped 4.81% in from $25.58 to $26.81 at 18:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is dropping 0.4% to $17,340.17, following the last session’s downward trend.

Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk provides information and communications technology, and telecommunications network services worldwide. The company operates through mobile, consumer, enterprise, Wholesale and International Business, and Other segments. The Mobile segment offers mobile voice, SMS, value added services, and mobile broadband services. The Consumer segment provides fixed wireline, pay TV, and internet services; and other telecommunication services to home customers. The Enterprise segment offers end-to-end solution to corporate and institutions. The Wholesale and International Business segment provides interconnection services, leased lines, satellite, very small aperture terminal, broadband access, information technology services, data, and internet services to other licensed operator companies and institutions. The Other segment offers digital content products, big data, business to business commerce, and financial services to individual and corporate customers. The company also engages in leasing of towers and other telecommunication services; provision of consultation service of hardware, computer software, and data center, as well as multimedia portal services; property development and management; trading service related to information and technology, multimedia, entertainment, and investment; and digital content exchange hub services. The company was founded in 1884 and is headquartered in Bandung, Indonesia.

More news about PT Telekomunikasi.

10. International Paper Company (IP)

Shares of International Paper Company dropped 0.69% in from $36.24 to $35.99 at 18:21 EST on Tuesday, after four sequential sessions in a row of gains. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

International Paper Company produces renewable fiber-based packaging and pulp products in North America, Latin America, Europe, and North Africa. It operates through Industrial Packaging and Global Cellulose Fibers segment. The company's Industrial Packaging segment manufactures containerboards, including linerboard, medium, whitetop, recycled linerboard, recycled medium, and saturating kraft. Its Global Cellulose Fibers segment provides fluff, market, and specialty pulps that are used in absorbent hygiene products, such as baby diapers, feminine care, adult incontinence, and other non-woven products; tissue and paper products; and non-absorbent end applications, including textiles, filtration, construction material, paints and coatings applications. In addition, it sells its products directly to end users and converters, as well as through agents, resellers, and distributors. The company was founded in 1898 and is headquartered in Memphis, Tennessee.

Moving Average

International Paper Company’s value is below its 50-day moving average of $36.27 and above its 200-day moving average of $34.10.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 56.6% and a negative 32.2%, respectively.

More news about International Paper Company.

11. Franco (FNV)

Shares of Franco jumped 0.35% in from $107.76 to $108.14 at 18:21 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is dropping 0.4% to $17,340.17, following the last session’s downward trend.

Franco-Nevada Corporation operates as a gold-focused royalty and streaming company in Latin America, the United States, Canada, and internationally. It operates through Mining and Energy segments. The company manages its portfolio with a focus on precious metals, such as gold, silver, and platinum group metals; and engages in the sale of crude oil, natural gas, and natural gas liquids. The company was founded in 1986 and is headquartered in Toronto, Canada.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 1.2% and positive 3.8% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 1.23B for the twelve trailing months.

More news about Franco.

12. Interactive Brokers Group (IBKR)

Shares of Interactive Brokers Group jumped by a staggering 13.09% in from $91.15 to $103.08 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is falling 0.92% to $15,630.78, following the last session’s downward trend.

Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in routing, executing, and processing trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.

Moving Average

Interactive Brokers Group’s value is way higher than its 50-day moving average of $88.65 and way higher than its 200-day moving average of $85.02.

Revenue Growth

Year-on-year quarterly revenue growth grew by 19%, now sitting on 4.34B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Interactive Brokers Group’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 17% and 19.7%, respectively.

More news about Interactive Brokers Group.

13. Pool Corporation (POOL)

Shares of Pool Corporation fell 3.63% in from $399.16 to $384.67 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.92% to $15,630.78, following the last session’s downward trend.

Pool Corporation distributes swimming pool supplies, equipment, and related leisure products in the United States and internationally. The company offers maintenance products, including chemicals, supplies, and pool accessories; repair and replacement parts for pool equipment, such as cleaners, filters, heaters, pumps, and lights; and building materials, such as concrete, plumbing and electrical components, functional and decorative pool surfaces, decking materials, tiles, hardscapes, and natural stones for pool installations and remodeling. It also provides pool equipment and components for new pool construction and the remodeling of existing pools; irrigation and related products, such as irrigation system components, and professional lawn care equipment and supplies; commercial products, including heaters, safety equipment, commercial decking equipment, and commercial pumps and filters. In addition, the company offers fiberglass pools, and hot tubs and packaged pool kits comprising walls, liners, braces, and coping for in-ground and above-ground pools; and other pool construction and recreational products comprising discretionary recreational and related outdoor living products, such as grills and components for outdoor kitchens. It serves swimming pool remodelers and builders; specialty retailers that sell swimming pool supplies; swimming pool repair and service businesses; irrigation construction and landscape maintenance contractors; and commercial pool operators and pool contractors. Pool Corporation was incorporated in 1993 and is headquartered in Covington, Louisiana.

Revenue Growth

Year-on-year quarterly revenue growth declined by 8.7%, now sitting on 5.63B for the twelve trailing months.

Sales Growth

Pool Corporation’s sales growth is negative 7% for the present quarter and 2.9% for the next.

More news about Pool Corporation.

14. Trip.com (TCOM)

Shares of Trip.com rose by a staggering 18.67% in from $34.92 to $41.44 at 18:21 EST on Tuesday, after three successive sessions in a row of gains. NASDAQ is falling 0.92% to $15,630.78, following the last session’s downward trend.

Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.

Sales Growth

Trip.com’s sales growth is 96.7% for the present quarter and 21.1% for the next.

Volatility

Trip.com’s last week, last month’s, and last quarter’s current intraday variation average was 1.33%, 0.67%, and 1.79%.

Trip.com’s highest amplitude of average volatility was 1.33% (last week), 1.59% (last month), and 1.79% (last quarter).

More news about Trip.com.

15. Veeva Systems (VEEV)

Shares of Veeva Systems jumped 5.04% in from $209.43 to $219.99 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

More news about Veeva Systems.

16. eBay (EBAY)

Shares of eBay jumped 5.88% in from $40.97 to $43.38 at 18:21 EST on Tuesday, after three consecutive sessions in a row of gains. NASDAQ is falling 0.92% to $15,630.78, following the last session’s downward trend.

eBay Inc. operates marketplace platforms that connect buyers and sellers in the United States and internationally. The company's marketplace platform includes its online marketplace at ebay.com and the eBay suite of mobile apps. Its platforms enable users to list, buy, and sell various products. The company was founded in 1995 and is headquartered in San Jose, California.

Sales Growth

eBay’s sales growth is 0.1% for the current quarter and 1% for the next.

More news about eBay.

17. Align Technology (ALGN)

Shares of Align Technology jumped by a staggering 16.59% in from $268.88 to $313.49 at 18:21 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.92% to $15,630.78, following the last session’s downward trend.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 8.2% and 7.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 3.86B for the twelve trailing months.

Yearly Top and Bottom Value

Align Technology’s stock is valued at $313.49 at 18:21 EST, way under its 52-week high of $413.20 and way above its 52-week low of $176.34.

More news about Align Technology.

18. Celanese (CE)

Shares of Celanese jumped 2.92% in from $145.33 to $149.57 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium for the food and beverage industry, and food protection ingredients, such as potassium sorbate and sorbic acid. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it provides redispersible powders (RDP) for use in construction applications, including flooring, plasters, insulation, tiling, and waterproofing. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.

Moving Average

Celanese’s value is higher than its 50-day moving average of $148.51 and way higher than its 200-day moving average of $126.59.

More news about Celanese.

19. Bristol (BMY)

Shares of Bristol jumped 0.56% in from $49.59 to $49.87 at 18:21 EST on Tuesday, after three successive sessions in a row of gains. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; Orencia for adult patients with active RA and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Onureg for the treatment of adult patients with AML; Inrebic, an oral kinase inhibitor indicated for the treatment of myelofibrosis; Camzyos for the treatment of adults with symptomatic obstructive HCM to enhance functional capacity and symptoms; Sotyktu for the treatment of adults with moderate-to-severe plaque psoriasis; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane, a protein-bound chemotherapy product. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

More news about Bristol.

20. CarMax (KMX)

Shares of CarMax rose 0.24% in from $70.33 to $70.50 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

CarMax, Inc., together with its subsidiaries, operates as a retailer of used vehicles in the United States. It operates in two segments, CarMax Sales Operations and CarMax Auto Finance. The company offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; and extended protection plans to customers at the time of sale, as well as sells vehicles that are approximately 10 years old and has more than 100,000 miles through wholesale auctions. It also provides reconditioning and vehicle repair services; and financing alternatives for retail customers across a range of credit spectrum through its CarMax Auto Finance and arrangements with various financial institutions. The company was founded in 1993 and is based in Richmond, Virginia.

Sales Growth

CarMax’s sales growth for the current quarter is 2.2%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 28.25B for the twelve trailing months.

Moving Average

CarMax’s worth is under its 50-day moving average of $72.26 and below its 200-day moving average of $74.36.

More news about CarMax.

21. Catalyst Pharmaceuticals (CPRX)

Shares of Catalyst Pharmaceuticals dropped 9.42% in from $15.12 to $13.70 at 18:21 EST on Tuesday, after three sequential sessions in a row of gains. NASDAQ is dropping 0.92% to $15,630.78, following the last session’s downward trend.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Moving Average

Catalyst Pharmaceuticals’s worth is below its 50-day moving average of $14.72 and above its 200-day moving average of $13.60.

Sales Growth

Catalyst Pharmaceuticals’s sales growth is 74.7% for the present quarter and 22.9% for the next.

Volatility

Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.04%, a negative 0.19%, and a positive 2.50%.

Catalyst Pharmaceuticals’s highest amplitude of average volatility was 2.04% (last week), 2.07% (last month), and 2.50% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 18.2% and a drop 7.7% for the next.

More news about Catalyst Pharmaceuticals.

22. E.I. du Pont de Nemours and Company (DD)

Shares of E.I. du Pont de Nemours and Company dropped 9.86% in from $75.13 to $67.72 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.4% to $17,340.17, following the last session’s downward trend.

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, and electroless and electrolytic metallization solutions, and electromagnetic shielding and thermal management solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for organic light emitting diode, and other display applications; provides high performance parts, and specialty silicone elastomers, and lubricants to automotive, aerospace, electronics, industrial, and healthcare markets; and photopolymer plates and platemaking systems used in flexographic printing, and digital inks for textile, commercial, and home-office printing applications. The Water & Protection segment provides engineered products and integrated systems for worker safety, water purification and separation, transportation, energy, medical packaging and building materials. The Corporate & Other segment offers auto adhesives and fluids; Multibase; and Tedlar products. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.

Yearly Top and Bottom Value

E.I. du Pont de Nemours and Company’s stock is valued at $67.72 at 18:21 EST, way below its 52-week high of $78.74 and way higher than its 52-week low of $61.14.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, E.I. du Pont de Nemours and Company’s stock is considered to be oversold (<=20).

More news about E.I. du Pont de Nemours and Company.

23. Bio-Rad (BIO)

Shares of Bio-Rad jumped 9.89% in from $312.71 to $343.64 at 18:21 EST on Tuesday, after three consecutive sessions in a row of gains. NYSE is falling 0.4% to $17,340.17, following the last session’s downward trend.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 1.8% and a negative 2.7%, respectively.

Volatility

Bio-Rad’s last week, last month’s, and last quarter’s current intraday variation average was 2.53%, 0.63%, and 1.39%.

Bio-Rad’s highest amplitude of average volatility was 2.53% (last week), 1.61% (last month), and 1.39% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.7%, now sitting on 2.67B for the twelve trailing months.

More news about Bio-Rad.

24. Public Service Enterprise Group (PEG)

Shares of Public Service Enterprise Group rose 3.2% in from $58.15 to $60.01 at 18:21 EST on Tuesday, after five sequential sessions in a row of gains. NYSE is dropping 0.4% to $17,340.17, following the last session’s downward trend.

Public Service Enterprise Group Incorporated, through its subsidiaries, operates as an energy company primarily in Mid-Atlantic United States. The company operates through PSE&G and PSEG Power. The PSE&G segment transmits electricity; distributes electricity and gas to residential, commercial, and industrial customers, as well as invests in solar generation projects, and energy efficiency and related programs; and offers appliance services and repairs. As of December 31, 2022, it had electric transmission and distribution system of 25,000 circuit miles and 864,000 poles; 55 switching stations with an installed capacity of 39,653 megavolt-amperes (MVA), and 235 substations with an installed capacity of 9,735 MVA; four electric distribution headquarters and five electric sub-headquarters; and 18,000 miles of gas mains, 12 gas distribution headquarters, two sub-headquarters, and one meter shop, as well as 56 natural gas metering and regulating stations. Public Service Enterprise Group Incorporated was incorporated in 1985 and is based in Newark, New Jersey.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Public Service Enterprise Group’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 11.77B for the twelve trailing months.

Moving Average

Public Service Enterprise Group’s worth is under its 50-day moving average of $60.18 and under its 200-day moving average of $61.20.

More news about Public Service Enterprise Group.

25. Toll Brothers (TOL)

Shares of Toll Brothers jumped 0.57% in from $103 to $103.59 at 18:21 EST on Tuesday, following the last session’s downward trend. NYSE is falling 0.4% to $17,340.17, following the last session’s downward trend.

Toll Brothers, Inc., together with its subsidiaries, designs, builds, markets, sells, and arranges finance for a range of detached and attached homes in luxury residential communities in the United States. It designs, builds, markets, and sells condominiums through Toll Brothers City Living. The company also develops a range of single-story living and first-floor primary bedroom suite home designs, as well as communities with recreational amenities, such as golf courses, marinas, pool complexes, country clubs, and fitness and recreation centers; and develops, operates, and rents apartments. In addition, it provides various interior fit-out options, such as flooring, wall tile, plumbing, cabinets, fixtures, appliances, lighting, and home-automation and security technologies. Further, the company owns and operates architectural, engineering, mortgage, title, land development, insurance, smart home technology, landscaping, lumber distribution, house component assembly, and component manufacturing operations. It serves luxury first-time, move-up, empty-nester, active-adult, and second-home buyers. Toll Brothers, Inc. was founded in 1967 and is headquartered in Fort Washington, Pennsylvania.

More news about Toll Brothers.